Abstract
Intravenous inoculation of a penicillin-resistant phage type 80/81 staphylococcus caused lethal infection in seven of eight untreated monkeys. Daily intragastric administration of 50 mg/kg given in two equal morning and afternoon doses of cyclacillin and nafcillin was followed by mortalities of four of four and two of four monkeys, respectively. After 100 mg per kg per day, three of four and one of four monkeys receiving cyclacillin and nafcillin, respectively, died. Thus, mortality in controls and cyclacillin-treated monkeys was seven of eight as compared to three of eight after nafcillin treatment. Although the staphylococcus was more resistant to cyclacillin (minimal inhibitory concentration = 7.80 μg/ml) than to nafcillin (minimal inhibitory concentration = 0.31 μg/ml), regular rapid absorption and high levels of the former suggested potential efficacy. However, the similar mortality in cyclacillin-treated and control monkeys indicated that the in vitro data did not, in this instance, conform to the in vivo observations.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Carlisle H. N., Saslaw S. Therapy of staphylococcal infections in monkeys. VI. Comparison of clindamycin, erythromycin, and methicillin. Appl Microbiol. 1971 Mar;21(3):440–446. doi: 10.1128/am.21.3.440-446.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hopper M. W., Yurchenco J. A., Warren G. H. Duration of therapeutic activity of aminoalicyclic penicillins against bacterial infections in mice. Antimicrob Agents Chemother (Bethesda) 1967;7:597–601. [PubMed] [Google Scholar]
- Perkins R. L., Carlisle H. N., Saslaw S. Cephalexin: in vitro bacterial susceptibility, absorption in volunteers, and antibacterial activity of sera and urine. Am J Med Sci. 1968 Aug;256(2):122–129. [PubMed] [Google Scholar]
- Roseman S. B., Weber L. S., Owen G., Warren G. H. Antimicrobial activity and pharmacological distribution of Wy-4508, an aminoalicyclic penicillin. Antimicrob Agents Chemother (Bethesda) 1967;7:590–596. [PubMed] [Google Scholar]
- Saslaw S., Carlisle H. N., Marietti M. Therapy of staphylococcal infections in monkeys. IV. Further comparison of triacetyloleandomycin and erythromycins. Appl Microbiol. 1969 Dec;18(6):1077–1083. doi: 10.1128/am.18.6.1077-1083.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Saslaw S., Carlisle H. N., Sparks J. Studies on therapy of staphylococcal infections in monkeys. V. Comparison of cephalexin, oxacillin, cloxacillin, dicloxacillin and nafcillin. Am J Med Sci. 1970 Feb;259(2):143–152. doi: 10.1097/00000441-197002000-00008. [DOI] [PubMed] [Google Scholar]
- Saslaw S., Carlisle H. N. Staphylococcal infection in normal and splenectomized monkeys. Proc Soc Exp Biol Med. 1966 Nov;123(2):565–571. doi: 10.3181/00379727-123-31544. [DOI] [PubMed] [Google Scholar]
- Saslaw S., Carlisle H. N. Studies of therapy of staphylococcal infections in monkeys. II. Comparison of cloxacillin, dicloxacillin, and leucomycin. Proc Soc Exp Biol Med. 1968 Jun;128(2):358–363. doi: 10.3181/00379727-128-33014. [DOI] [PubMed] [Google Scholar]
- Saslaw S., Carlisle H. N. Studies on therapy of staphylococcal infections in monkeys. 3. Comparison of cephalothin, cephaloridine and cephalexin. Am J Med Sci. 1968 Sep;256(3):136–149. doi: 10.1097/00000441-196809000-00002. [DOI] [PubMed] [Google Scholar]
- Saslaw S., Carlisle H. N. Studies on therapy of staphylococcal infections in monkeys. I. Comparison of cloxacillin, triacetyloleandomycin and erythromycin. Proc Soc Exp Biol Med. 1967 Aug-Sep;125(4):1168–1173. doi: 10.3181/00379727-125-32304. [DOI] [PubMed] [Google Scholar]
- Yurchenco J. A., Hopper M. W., Warren G. H. Therapeutic activity of aminoalicyclic penicillins in bacterial infections in mice. Antimicrob Agents Chemother (Bethesda) 1967;7:602–608. [PubMed] [Google Scholar]